RankAlpha logo
Back to Rankings

ALZN

Alzamend NeuroF
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-06-02
View Chart
+
Peers tracked
8
U.S. public peers
Grade Position
Below peers
vs peer average
ALZN vs peer average
42/100
ALZN vs. peer average (F vs. D)
Grade spread
B 1 · D 1 · F 6
Graded peers loaded
Coverage
8 graded
100% of tracked

Peer overview

REVB is the first available peer comparator.

Same sector: Pharmaceuticals, Biotechnology & Life Sciences · Cap $4.14M

✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
Top peerREVBRevelation Biosciences
ALZN
Alzamend Neuro
REVB
Revelation Biosciences
Grade
F
B
Momentum
18
86
Value
41
57
Sentiment
-
30
Setup Bias
Net Neutral
-
Market Cap
-
-
Posture
Defensive
Constructive
Open Side-by-Side ComparisonCompare all

Grade position vs REVB

ALZN / REVB
Grade Position
Below peers
ALZN vs. peer average (F vs. D)
42/100
Momentum
18
REVB
Value
41
REVB
Sentiment
-
-

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank
Ticker
Company
Grade
Grade score
vs ALZN
1
REVB
Revelation Biosciences Inc Common
B
80/100
-3
2
CDT
CDT Equity Inc Common
F
20/100
Even
3
GLMD
Galmed Pharmaceuticals Ltd Common
F
20/100
Even
4
DCOY
Decoy Therapeutics Inc Common
F
20/100
Even
5
PBM
Psyence Biomedical Ltd Common
F
20/100
Even
REVB is the first peer returned for this comparison set.